Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

Study Overview

• Status: Active, not recruiting
• Conditions: Patient Satisfaction; Postoperative Nausea; Postoperative Vomiting; PACU Length of Stay
• Intervention / Treatment: Dietary supplement: Coffee

Detailed Description

Decreasing the length of stay in PACU for surgical patient is a pertinent outcome. The shorter length of stay can achieve higher patient engagement scores, while simultaneously increasing the productivity of the unit. This is achieved by making more beds available for new patients coming from the operating room (OR). One thought was that coffee would benefit the investigator's patients experience through a number of pathways. Initially, the stimulant effect of coffee would create a more alert patient. A more alert patient is more likely to comprehend home care instruction and be ready for discharge earlier. Coffee is often used as a remedy for morning sickness. Ideally the act of drinking coffee or even smelling the coffee may decrease the occurrence of Post-Operative Nausea and Vomiting (PONV) in investigator's patient population. Finally, patients frequently state that the inability to drink their morning coffee is often more difficult than not being able to eat prior to surgery. By allowing those to drink coffee in PACU this would make the patient feel that they are being cared for on an emotional level, in addition to a physical level.

• Study Type: Interventional
• Enrollment (Actual): 168
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Rachel Baker, PhD, RN; Phone Number: 5135696191; Email: Rachel_Baker2@trihealth.com

Study Locations

• United States
  • Ohio
    • Cincinnati, Ohio, United States, 45242
      • Bethesda North Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion criteria:

1. 18 years old or older
2. Admitted to Bethesda North Minimally Invasive Surgery Center
3. Reports to consume at least one cup of coffee a day for at least 5 days in a week

Exclusion Criteria

1. History of PONV
2. Pre-existing cardiac arrhythmias
3. History of seizure disorder
4. Pregnant

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Patients receiving coffee postoperatively; Patients who self-identify as coffee drinkers and receive coffee postoperatively	Dietary supplement: Coffee; Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)
No Intervention: Patients not receiving coffee postoperatively; Patients who self-identify as coffee drinkers and do not receive coffee postoperatively

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
PACU length of stay	Post-anesthesia Care Unit length of stay	6 hours

Collaborators and Investigators

• Sponsor: TriHealth Inc.
• Investigators: Principal Investigator: Brandon Ballhaus, BSN, RN, TriHealth Inc.

Study record dates

Study Major Dates

• Study Start (Actual): October 25, 2018
• Primary Completion (Actual): July 1, 2023
• Study Completion (Estimated): October 1, 2023

Study Registration Dates

• First Submitted: October 17, 2018
• First Submitted That Met QC Criteria: October 18, 2018
• First Posted (Actual): October 19, 2018

Study Record Updates

• Last Update Posted (Actual): July 5, 2023
• Last Update Submitted That Met QC Criteria: July 3, 2023
• Last Verified: July 1, 2023

More Information

Terms related to this study

• Keywords: coffee; PACU length of stay
• Additional Relevant MeSH Terms: Pathologic Processes; Postoperative Complications; Signs and Symptoms, Digestive; Nausea; Vomiting; Postoperative Nausea and Vomiting
• Other Study ID Numbers: 18-050

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No